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Abstract
Background: The clinical manifestations of Q fever endocarditis are protean in nature. Mixed
cryoglobulinemia type II is rarely a facet of the presenting clinical manifestations of Q fever
endocarditis.
Case presentation: We report a case of a 65-year-old pensioner with such an association and
review the literature. As transesophageal echocardiograms are usually normal and blood cultures
are usually negative in Q fever endocarditis, many of the manifestations (fever, rash,
glomerulonephritis/evidence of renal disease, low serum C4 complement component, presence of
mixed type II cryoglobulin, constitutional symptoms as arthralgias and fatigue) can be attributed to
Mixed cryoglobulinemia type II per se. The use of Classic Duke Endocarditis Service criteria does
not always suffice for the diagnosis of Q fever.
Conclusion:  The application of the modified criteria proposed by Fournier et al for the
improvement of the diagnosis of Q fever endocarditis will help to reach the diagnosis earlier and
thus reduce the high mortality of the disease. We would like to stress the importance of ruling out
the diagnosis of Q fever endocarditis in cases of mixed type II cryoglobulinemia.
Background
Clinical manifestations of Q fever endocarditis are pro-
tean in nature. Mixed cryoglobulinemia type II is rarely a
facet of the presenting clinical manifestations of Q fever
endocarditis.
Case presentation
A 65-year-old pensioner was admitted to our hospital in
May 2000 because of a two-month history of fever up to
38°C. This was accompanied by fatigue, arthralgia, mus-
cle weakness and night sweating. Seven months ago he
reported a similar clinical constellation, which lasted
approximately three weeks, and at that time a presump-
tive diagnosis of infection due to Brucella melitensis was
made elsewhere, based on the findings of ELISA
(increased IgM antibody titre and a fourfold increase of
IgG antibody titre in samples taken at two different peri-
ods). He received ciprofloxacin for presumed brucellosis
for a total of ten weeks and remained asymptomatic for
four months. During the previous 8 months the patient
had noticed evanescent skin eruptions of red to purple
papules, which remained only for a few days each time
but left areas of brown hyperpigmentation.
Past medical history: Fifteen years ago he had surgery for
a stenosed mitral valve and a prosthetic Starr-Edwards was
inserted. He is on asenocoumarol and digoxin since. He
was neither smoking nor consuming alcohol.
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On examination: Blood pressure: 120/70 mm Hg. Tem-
perature: 38°C. Pulse: 70 per minute irregularly irregular.
Respirations: 12 per minute. He looked emaciated and ill
though not in acute stress. His sclerae were pale. A scar of
the previous cardiothoracic operation was evident. The
first heart sound had a metallic resonance. A soft systolic
1–2/6 murmur could be heard at the apex and the lower
left sternal edge. The liver was palpable 2 cm below the
right hypochondrium. The tip of the spleen was palpable
during inspiration. A palpable purpuric rash was present
on the legs, only for roughly two days, as were areas of
hyperpigmentation (figure).
Investigations revealed a normochromic normocytic ane-
mia (hemoglobin: 11,4 gr/L) accompanied by decreased
renal function (serum creatinine: 159,1 µmol/L), an ESR
of 125 mm/ 1st hour and hyperglobulinemia (5,8 gr/dl).
Serum protein electrophoresis revealed increased γ globu-
lin: 41,4% (normal: 11,0–22,2%), decreased albumin:
34% (normal: 51,2–63%) and normal α1 globulin,  α2
globulin and β globulin. Quantitative estimation showed:
IgG: 4930 mg% (normal: 694–1618 mg%), IgA: 821 mg%
(normal: 69–378 mg%), IgM: 533 mg% (normal: 60–263
mg%), κ: 3270 mg% (normal: 574–1276 mg%) and λ:
1740 mg% (269–638 mg%). Rheumatoid factor was
markedly increased at 1430 IU/L (normal: <20 IU/L). Cry-
oglobulins were present in the serum and the correspond-
ing cryocrite was 3,3%. In particular immunofixation of
serum proteins at 37°C revealed: a. an IgM κ paraprotein
in the gamma globulin region and b. a diffuse polyclonal
increase of IgG, which corresponded to diffuse κ chains.
Serum complement showed a borderline low normal C4:
20,5 mg/dl (normal: 20,5–49 mg/dl) whilst C3 was nor-
mal. Urine dipstick and microscopy disclosed: protein +,
hemoglobin +++, 2–3 leucocytes per optical field, 30–40
RBC per optical field, rare hemorrhagic casts, rare RBC
casts and mixed cellular casts.
As the clinical manifestations and laboratory data of our
patient dictated, we pursued ruling out infective endocar-
ditis and various other infectious causes of mixed type II
cryoglobulinemia. Blood and urine cultures were repeat-
edly normal. Two transesophageal echocardiographs dur-
ing his hospitalization performed by an experienced
board certified cardiologist did neither show vegetations
nor any valve malfunction. Wright agglutination test,
VDRL and serological tests for HBV, HCV, EBV, CMV and
HIV were all negative. HCV RNA was negative in the
serum, the cryoprecipitate and the supernatant. Blood cul-
tures and bone marrow cultures were negative for Brucel-
lae, Mycobacteria and Leishmaniae. Blood was tested for
Brucella DNA by PCR and was negative. Abdominal ultra-
sound revealed reduced kidney size (96 mm) and hepat-
osplenomegaly. Computed tomography of the thorax and
abdomen was otherwise normal. A whole body scintigra-
phy with gallium 67 was normal.
Based on the findings of the purpuric rash of the lower
limbs, the borderline low serum C4 complement compo-
nent, the findings of renal disease (increased creatinine,
hematuria, red blood cells casts), the presence of mixed
type II cryoglobulinemia (as already mentioned, immun-
ofixation of serum proteins at 37°C revealed an IgM κ par-
aprotein in the gamma globulin region and a diffuse
polyclonal increase of IgG, which corresponded to diffuse
κ chains) and the normal transesophageal echocardio-
grams and negative tests for viruses (HCV, HBV, EBV,
CMV) a working diagnosis of idiopathic mixed type II cry-
oglobulinemia was made. Strict need for anticoagulation
(due to his prosthetic mitral valve) precluded biopsy of
afflicted organs. The patient was prescribed a 15 mg pred-
nisolone dose per os daily.
He experienced temporary relief of his symptoms for a
period of three weeks. He subsequently presented with
dyspnoea, relapse of fever and a worsened holosystolic 4/
6 murmur at the cardiac apex, which radiated to the axilla.
Transesophageal ultrasound at this time showed paraval-
vular leak of the prosthetic mitral valve. Antibodies
against Coxiella burnetii [using indirect microimmunoflu-
orescence with the Q fever reagent of MRL (now Focus)]
were positive phase I IgG: 1/64000, phase I IgM: 1/1024.
Phase II IgM antibodies were negative and phase II IgG
positive at 1/64000. Polymerase chain reaction for the
detection of Coxiella burnetii DNA in blood was positive.
A Trans-PCR was performed using primers Trans1 (5'-TAT
GTA TCC ACC GTA GCC AGT C-3'), Trans2 (5'-CCC AAC
AAC ACC TTC TTA TTC-3') which flanked a 687-bp trans-
posonlike repetitive region of the C. burnetii genome. Two
internal primers were used as well namely Trans3 (5'-GTA
ACG ATG CGC AGG CGA T-3') and Trans4 (5'-CCA CCG
CTT CGC TCG CTA-3'). Serology was negative for Chlamy-
dia psittaci, Chlamydia pneumoniae, Chlamydia trachomatis,
Legionella pneumophila, Rickettsia mooseri and  Rickettsia
conorii. After two weeks of treatment with doxycycline 100
mg bd per os and hydroxychloroquine 200 mg bd per os
he had his Starr-Edwards valve replaced by a prosthetic
ATS 25 mmHg mitral valve. Today approximately five
years after the operation he remains in excellent health
with no cryoglobulins detected and with a dramatic
decrease in antibody titres against Coxiella burnetii while
on the same regimen, which was recently discontinued.
The duration of treatment with doxycyclin-hydroxychlo-
roquine was 5 years.
Discussion
Clinical manifestations of chronic Q fever are endocardi-
tis, isolated fever, osteoartricular infections, chronic hepa-
titis and rarely chronic pericarditis, skin lesions,BMC Infectious Diseases 2006, 6:32 http://www.biomedcentral.com/1471-2334/6/32
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interstitial lung fibrosis and pseudotumor of the lung
[1,2]. These protean ailments have led to the classification
of chronic Q fever into 1. Q fever endocarditis 2. Chronic
Q fever with underlying cardiac or vascular disease but
with no evidence of endocarditis 3. Chronic Q fever with-
out cardiovascular involvement [3].
The incidence of endocarditis due to Coxiella burnetii in
the general population is approximately 1 per 106. Early
diagnosis is hampered by the variation of its clinical man-
ifestations. It is a severe and often fatal disease [4]. Mortal-
ity approaches 100% without treatment, whilst therapy
reduces this percentage to 10–24% [1]. Endocarditis is
consisting 16–73% of all chronic Q fever, being so the
major clinical representative. A lag of 12–24 months from
onset to diagnosis of Q fever endocarditis (8 months in
our patient's case) is not unusual due to the non-specific
symptoms and signs and because vegetations are either to
small to be depicted on echocardiography or are com-
pletely absent. In a series of 168 patients with C. burnetii
endocarditis only 40% had vegetations [5]. This was also
initially the case in our patient where during his hospital-
isation two transesophageal echocardiograms performed
by an expert cardiologist did not show any abnormality.
The other major criterion (namely two separate blood cul-
tures according to classic Duke Endocarditis Service crite-
ria) for the diagnosis of infectious endocarditis could not
be met in our patient, as culture of Coxiella burnetii cannot
be achieved in most routine laboratories of the world
because of the biohazard associated with its culture. As
transesophageal echocardiograms are usually normal and
blood cultures are usually negative in Q fever endocardi-
tis, a modification of the diagnostic criteria by the Duke
Endocarditis Service has been proposed: Q fever serology
(1/800 antiphase I immunoglobulin G cut off) and a sin-
gle blood culture of Coxiella burnetii should be regarded as
major criteria and not as minor ones [4]. This amendment
helped to improve the diagnosis of Q fever endocarditis in
as much as 20% of the cases in the described case series
[4].
Cryoglobulins are detected in 84–95% of all cases of
infectious endocarditis and in less than 5% in Q fever
endocarditis [6]. Q fever endocarditis can mimic the clin-
ical syndrome of mixed cryoglobulinemia type II. This
happens because many of the characteristics are shared by
the two diseases (fever, rash, glomerulonephritis/evidence
of renal disease, low C4 complement component, pres-
ence of mixed type II cryoglobulin, constitutional symp-
toms such as fatigue, arthralgia). As transesophageal
echocardiograms are usually normal and blood cultures
are usually negative in Q fever endocarditis, many of these
clinical manifestations can be attributed to Mixed cry-
oglobulinemia type II per se [[7-11]]. Thus problems of
differential diagnosis arise.
We reviewed the five other cases of the literature where
such issues of differential diagnosis between mixed cry-
oglobulinemia type II and Q fever endocarditis emerged
and caused a delay in diagnosis [see Additional file 1].
Our patient and the other five patients with mixed cry-
oglobulinemia in association with Q fever endocarditis
described in the literature, have the following features in
common: presence of a prosthetic valve, normal echocar-
diograms at least at an initial stage of the disease, and
presence of a rash (mainly purpuric) on the lower limbs.
Two of these patients were unnecessarily treated with
some form of immunosuppressive therapy (steroids,
cyclophosphamide, splenectomy), as was the case for our
patient as well. The common denominator is that eventu-
ally diagnosis was reached by the use of serology for Cox-
iella burnetii, which was positive in all reported cases. A
repeat echocardiogram showed abnormalities in two of
the five cases, while no data are given for two cases. We
want to stress that in our patient even a second trans-
esesophageal echocardiogram was negative. We think that
by having applied the modified Duke Endocarditis Service
criteria in all these cases (including ours), which include
serology against Coxiella burnetii as a major and not as a
minor criterion, diagnosis would have been reached ear-
lier.
In the course of his disease, our patient underwent an
extensive workup in order to rule out the commonest
causes of mixed type II cryoglobulinemia. Among them
Hepatitis C virus infection having a dominant role [12] was
excluded not only by serology but also with a search for
HCV RNA in the cryoprecipitate and its supernatant.
Because of his prior presumed brucellosis we searched
meticulously for this possibility. We think that this previ-
ous diagnosis, which was based on positive ELISA assay,
was a serological cross-reaction with Coxiella burnetii.
Whilst Coxiella burnetii has been reported in the past to
cross-react with a variety of organisms (such as Rickettsia
ricketsii, Ehrlichia chaffeensis, Bartonella quintana, Bartonella
henselae, L. pneumophila, L. micdadei, Chlamydia spp and
Human granulocytic ehrlichiosis agent) [13], this is to the
best of our knowledge the first case in the literature where
such an association exists in conjunction to Brucella
melitensis. We believe that his prior response to cipro-
floxacin can be explained by the fact that this antibiotic
has good efficiency not only for Brucella spp. infections
(though relapses are not uncommon) but also for Coxiella
burnetii infections. Bartonella quintana and Bartonella hense-
lae are important causes of culture negative endocarditis
with vegetations found in 84% of these patients [5].BMC Infectious Diseases 2006, 6:32 http://www.biomedcentral.com/1471-2334/6/32
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Therapy of chronic Q fever prosthetic valve endocarditis
involves surgical replacement of the infected valve, as it is
not likely for the patient to respond to conservative means
alone [14]. The cardiothoracic operation per se can lead to
recurrence of the disease [15,16]. The two prevailing regi-
mens for treatment involve doxycycline (200 mg) with
hydroxychloroquine (200–800 mg) for eighteen months
or doxycycline at the same dose plus ofloxacin (600 mg)
for four years [17]. Many believe that treatment is needed
for a lifetime, since late recurrences occur in as many as
50% after treatment discontinuation [3,17]. Our patient
was on the first regimen (dose for hydroxychloroquine
400 mg) until recently and is doing extremely well. In
addition no cryoglobulins are detected, the IgG titer
against phase I has fallen to 1/2048 and the IgG titer
against phase II has fallen to 1/2048.
Conclusion
In cases of mixed type II cryoglobulinemia, chronic infec-
tion due to Coxiella burnetii should be ruled out, while
modified Duke Endocarditis Service criteria will help to
pick up the diagnosis earlier in difficult cases.
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